AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Immudapt-S 360 Tablet DR

Prescription Icon
Prescription Required

Marketer

Biowision Life Sciences Pvt Ltd

Salt Composition

Mycophenolate sodium (360mg)

Overview Immudapt-S 360 Tablet DR

Transplant recipients often use immunosuppressant medication like Immudapt-S 360 Tablet DR to prevent organ rejection. This drug, administered alongside other medications, reduces the body's immune response, thus protecting the transplanted organ (e.g., kidney, heart, liver). Dosage varies based on the transplant type; adhere strictly to your physician's prescription. This medication can be taken with or without food; swallow whole – never crush, chew, or break the tablet. Consistent use is crucial to maximize effectiveness and prevent rejection; discontinuation significantly raises rejection risk. Long-term therapy is usually required. Common side effects include gastrointestinal upset (nausea, vomiting, diarrhea, abdominal pain), headache, hypertension, and alterations in white blood cell counts. Immunosuppression increases infection susceptibility and cancer risk. A comprehensive list of potential side effects, some serious and requiring immediate medical attention, should be discussed with your doctor. Due to the risk of birth defects and miscarriage, this medicine is contraindicated during pregnancy, breastfeeding, or pregnancy planning. Consult your physician before starting Immudapt-S 360 Tablet DR if you have any infections, unusual bleeding or bruising, or a history of digestive issues. Complete disclosure of all other medications is essential due to potential drug interactions. Regular blood tests to monitor blood cell counts are necessary; report any unexplained bruising, bleeding, sore throat, mouth sores, or fever immediately.

Uses of Immudapt-S 360 Tablet DR

Avoiding graft rejection in recipients of organ transplants

Major Benefits of Immudapt-S 360 Tablet DR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Immudapt-S 360 Tablet DR whole; avoid crushing, chewing, or fracturing it. Consumption may coincide with meals or be taken independently, although consistent timing is recommended.

Common Side effects of Immudapt-S 360 Tablet DR:

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain
  • Headache
  • High blood pressure
  • Decreased white blood cell count (neutrophils)
  • Bacterial infection
  • Fungal infection
  • Pneumonia
  • Increased uric acid level in blood
  • Electrolyte imbalance
  • Anxiety
  • Breathlessness
  • Increased creatinine level in blood
  • Anemia (low number of red blood cells)
  • Acne
  • Muscle pain

How to use Immudapt-S 360 Tablet DR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Immudapt-S 360 Tablet DR. Ingest the tablet whole; do not chew, crush, or divide it. This medication can be administered with or without food, however, consistent timing is recommended.

How Immudapt-S 360 Tablet DR works:

Immudapt-S 360 DR tablets function as an immunosuppressant, mitigating the body's immune response to prevent organ transplant rejection.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse reactions associated with the concurrent use of Immudapt-S 360 Tablet DR and alcohol.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Immudapt-S 360 Tablet DR during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in potentially life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Immudapt-S 360 Tablet DR are incompatible; evidence indicates potential infant harm from this medication.

DrivingDrivingSAFE

Driving ability is typically unaffected by Immudapt-S 360 Tablet DR.

KidneyKidneyCAUTION

Patients with severe kidney impairment should use Immudapt-S 360 Tablet DR cautiously. Dosage modification for Immudapt-S 360 Tablet DR might be necessary; physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

Use of Immudapt-S 360 Tablet DR in patients with liver conditions appears to present minimal risk. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.

What if you forget to take Immudapt-S 360 Tablet DR :

Should you forget to take your Immudapt-S 360 Tablet DR, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Immudapt-S 360 Tablet DR

LabelValue
Type of Compound Isobenzofuranone derivative
Potential for Dependence None.
Type of Medication Cancer-fighting drugs
Mechanism of Action Drugs suppressing the immune system: purine derivatives

FAQs on Immudapt-S 360 Tablet DR

Azathioprine 360 mg extended-release tablets are an immunosuppressant medication. This prescription aims to facilitate your body's acceptance of the transplanted kidney. The medication achieves this by modulating your immune system's response to the foreign organ, thereby reducing the risk of rejection. This action promotes the integration of the transplanted kidney.
Taking Immudapt-S 360 Tablet DR may elevate the risk of developing specific cancers, including skin cancer and lymphoma. Minimize sun exposure when outdoors, use protective apparel, and apply sunscreen. Consult your physician immediately if you notice any new skin lesions, alterations in the size or color of moles, irregular brown or black skin spots, asymmetrical sores, unusual skin changes, non-healing sores, unexplained fever, persistent fatigue, weight loss, or pain/swelling in the lymph nodes (neck, groin, or armpits).
Immudapt-S 360 Tablet DR is a non-steroidal, non-chemotherapeutic immunosuppressant. Its mechanism involves modulating the immune system to prevent organ rejection following transplantation. A frequent adverse reaction associated with Immudapt-S 360 Tablet DR is alopecia.
To assess potential impacts on blood cell levels, kidney function, and liver health—effects associated with Immudapt-S 360 Tablet DR—a preliminary blood test will be administered prior to commencing treatment. Ongoing blood monitoring throughout the treatment period is necessary to detect any hematological alterations. This regular testing facilitates assessment of treatment efficacy and early identification of adverse reactions.
Immudapt-S 360 Tablet DR reduces immune system activity; it's an immunosuppressant. Because your immunity is compromised, exposure to chickenpox or shingles could lead to infection. Your physician's cautionary advice is therefore crucial. Contact your doctor promptly should you develop either illness; specialized care may be necessary.
Avoid Immudapt-S 360 Tablet DR if you are pregnant or intend to become pregnant. First-trimester pregnancies carry a significantly elevated miscarriage risk. Fetal birth defects are also a potential consequence. Consequently, employ two reliable contraceptive methods concurrently for four weeks prior to commencing Immudapt-S 360 Tablet DR, throughout treatment, and for six weeks post-treatment. Your physician will recommend appropriate methods. Combining a second contraceptive method with oral contraceptives is crucial, as Immudapt-S 360 Tablet DR can diminish their efficacy.
Reliable contraception should be used by either the male or female partner throughout treatment with Immudapt-S 360 Tablet DR and for three months afterward. Male patients must refrain from donating semen during treatment and for three months post-treatment.
Immudapt-S 360 Tablet DR
1,051
MRP 1,280
17% off